Alan L. Epstein

Person

Pasadena, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized anti-nuclear antibodies for targeting necrosis in cancer...
- Patent number 12,258,421
- Issue date Mar 25, 2025
- CANCER THERAPEUTICS LABORATORIES, INC.
- Alan Epstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lym-1 and Lym-2 antibody compositions and improved car constructs
- Patent number 11,667,715
- Issue date Jun 6, 2023
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-nuclear antibodies for targeting necrosis in cancer...
- Patent number 11,384,157
- Issue date Jul 12, 2022
- CANCER THERAPEUTICS LABORATORIES, INC.
- Alan Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Car t-cell therapy directed to LHR for the treatment of solid tumors
- Patent number 11,136,401
- Issue date Oct 5, 2021
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD20 scFv-ELPs methods and therapeutics
- Patent number 10,961,317
- Issue date Mar 30, 2021
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
OX40L fusion protein for the immunotherapy of tumors of veterinary...
- Patent number 10,196,435
- Issue date Feb 5, 2019
- University of Southern California
- Alan L. Epstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human myeloid derived suppressor cell cancer markers
- Patent number 9,746,480
- Issue date Aug 29, 2017
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cancer targeted innate immunity
- Patent number 9,522,958
- Issue date Dec 20, 2016
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human myeloid derived suppressor cell cancer markers
- Patent number 8,883,497
- Issue date Nov 11, 2014
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for cancer immunotherapy
- Patent number 8,795,672
- Issue date Aug 5, 2014
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for cancer immunotherapy
- Patent number 8,545,838
- Issue date Oct 1, 2013
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination cancer immunotherapy with co-stimulatory molecules
- Patent number 8,268,788
- Issue date Sep 18, 2012
- University of Southern California
- Alan Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination cancer immunotherapy with co-stimulatory molecules
- Patent number 8,207,130
- Issue date Jun 26, 2012
- University of Southern California
- Alan Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using interleukin-2 mutants with reduced toxicity
- Patent number 8,124,066
- Issue date Feb 28, 2012
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic use of interleukin-2 mutants
- Patent number 7,803,361
- Issue date Sep 28, 2010
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination cancer immunotherapy with co-stimulatory molecules
- Patent number 7,696,175
- Issue date Apr 13, 2010
- University of Southern California
- Alan Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic use of interleukin-2 mutants
- Patent number 7,514,073
- Issue date Apr 7, 2009
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-2 mutants with reduced toxicity
- Patent number 7,371,371
- Issue date May 13, 2008
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the diagnosis of neoplastic tissue comprising administer...
- Patent number 6,737,064
- Issue date May 18, 2004
- The University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopermeability-enhancing conjugates
- Patent number 6,696,276
- Issue date Feb 24, 2004
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopermeability-enhancing conjugates
- Patent number 6,524,823
- Issue date Feb 25, 2003
- The University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopermeability enhancing peptide of human interleukin-2 and immun...
- Patent number 6,403,096
- Issue date Jun 11, 2002
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopermeability enhancing immunoconjugates
- Patent number 6,274,343
- Issue date Aug 14, 2001
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Detection of necrotic malignant tissue and associated therapy
- Patent number 6,071,491
- Issue date Jun 6, 2000
- Techniclone, Inc.
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Detection of necrotic malignant tissue and associated therapy
- Patent number 6,017,514
- Issue date Jan 25, 2000
- Techniclone Inc.
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopermeability enhancing immunoconjugates
- Patent number 6,007,817
- Issue date Dec 28, 1999
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Vasopermeability enhancing peptide of human interleukin-2 and immun...
- Patent number 6,008,319
- Issue date Dec 28, 1999
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies with reduced net positive charge
- Patent number 5,990,286
- Issue date Nov 23, 1999
- Techniclone, Inc.
- Leslie A. Khawli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Detection of necrotic malignant tissue and associated therapy
- Patent number 5,882,626
- Issue date Mar 16, 1999
- Cancer Biologics, Inc.
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified antibodies
- Patent number 5,194,594
- Issue date Mar 16, 1993
- Techniclone, Inc.
- Leslie A. Khawli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
- Publication number 20250129171
- Publication date Apr 24, 2025
- University of Southern California
- Alan L. Epstein
- G01 - MEASURING TESTING
Information Patent Application
HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
- Publication number 20240392011
- Publication date Nov 28, 2024
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS
- Publication number 20240150470
- Publication date May 9, 2024
- University of Southern California
- Alan L. Epstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CpG IMMUNOCONJUGATES FOR CANCER THERAPY
- Publication number 20230331849
- Publication date Oct 19, 2023
- University of Southern California
- Alan Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER...
- Publication number 20230027730
- Publication date Jan 26, 2023
- Cancer Therapeutics Laboratories, Inc.
- Alan EPSTEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS
- Publication number 20220056139
- Publication date Feb 24, 2022
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
- Publication number 20210403585
- Publication date Dec 30, 2021
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
- Publication number 20210070864
- Publication date Mar 11, 2021
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER...
- Publication number 20200157246
- Publication date May 21, 2020
- Cancer Therapeutics Laboratories, Inc.
- Alan EPSTEIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TUMOR NECROSIS TARGETING COMPOSITIONS AND METHODS
- Publication number 20200147230
- Publication date May 14, 2020
- Cancer Therapeutics Laboratories, Inc.
- Alan EPSTEIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD20 scFv-ELPs METHODS AND THERAPEUTICS
- Publication number 20200079868
- Publication date Mar 12, 2020
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20200016201
- Publication date Jan 16, 2020
- University of Southern California
- Alan L. Epstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GITR AGONISTS, AND METHODS OF USE THEREOF
- Publication number 20190300619
- Publication date Oct 3, 2019
- University of Southern California
- Omid Akbari
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
- Publication number 20190119385
- Publication date Apr 25, 2019
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SECRETORY TNT CAR CELL IMMUNOTHERAPY
- Publication number 20180291089
- Publication date Oct 11, 2018
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAR T-CELLS FOR THE TREATMENT OF B7-H4 EXPRESSING SOLID TUMORS
- Publication number 20180118831
- Publication date May 3, 2018
- University of Southern California
- Alan L. Epstein
- G01 - MEASURING TESTING
Information Patent Application
CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
- Publication number 20180112003
- Publication date Apr 26, 2018
- University of Southern California
- Alan L. Epstein
- G01 - MEASURING TESTING
Information Patent Application
LYM-1 AND LYM-2 TARGETED CAR CELL IMMUNOTHERAPY
- Publication number 20160355590
- Publication date Dec 8, 2016
- Alan L. Epstein
- G01 - MEASURING TESTING
Information Patent Application
CD20 scFv-ELPs METHODS AND THERAPEUTICS
- Publication number 20150218280
- Publication date Aug 6, 2015
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS
- Publication number 20150204887
- Publication date Jul 23, 2015
- University of Southern California
- Alan L. EPSTEIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OX40L FUSION PROTEIN FOR THE IMMUNOTHERAPY OF TUMORS OF VETERINARY...
- Publication number 20150191525
- Publication date Jul 9, 2015
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY
- Publication number 20140099305
- Publication date Apr 10, 2014
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS
- Publication number 20120276004
- Publication date Nov 1, 2012
- University of Southern California
- Alan L. Epstein
- G01 - MEASURING TESTING
Information Patent Application
CANCER TARGETED INNATE IMMUNITY
- Publication number 20120076804
- Publication date Mar 29, 2012
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC USE OF INTERLEUKIN-2 MUTANTS
- Publication number 20110091413
- Publication date Apr 21, 2011
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION CANCER IMMUNOTHERAPY WITH CO-STIMULATORY MOLECULES
- Publication number 20110002921
- Publication date Jan 6, 2011
- University of Southern California
- Alan Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION CANCER IMMUNOTHERAPY WITH CO-STIMULATORY MOLECULES
- Publication number 20110002920
- Publication date Jan 6, 2011
- University of Southern California
- Alan Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY
- Publication number 20090274653
- Publication date Nov 5, 2009
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY
- Publication number 20070141025
- Publication date Jun 21, 2007
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Interleukin-2 mutants with reduced toxicity
- Publication number 20060292116
- Publication date Dec 28, 2006
- University of Southern California
- Alan L. Epstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Alan L. Epstein

Person

Patents Grantslast 30 patents

Humanized anti-nuclear antibodies for targeting necrosis in cancer...

Lym-1 and Lym-2 antibody compositions and improved car constructs

Humanized anti-nuclear antibodies for targeting necrosis in cancer...

Car t-cell therapy directed to LHR for the treatment of solid tumors

CD20 scFv-ELPs methods and therapeutics

OX40L fusion protein for the immunotherapy of tumors of veterinary...

Human myeloid derived suppressor cell cancer markers

Cancer targeted innate immunity

Human myeloid derived suppressor cell cancer markers

Compositions and methods for cancer immunotherapy

Compositions and methods for cancer immunotherapy

Combination cancer immunotherapy with co-stimulatory molecules

Combination cancer immunotherapy with co-stimulatory molecules

Methods of using interleukin-2 mutants with reduced toxicity

Therapeutic use of interleukin-2 mutants

Combination cancer immunotherapy with co-stimulatory molecules

Therapeutic use of interleukin-2 mutants

Interleukin-2 mutants with reduced toxicity

Method for the diagnosis of neoplastic tissue comprising administer...

Vasopermeability-enhancing conjugates

Vasopermeability-enhancing conjugates

Vasopermeability enhancing peptide of human interleukin-2 and immun...

Vasopermeability enhancing immunoconjugates

Detection of necrotic malignant tissue and associated therapy

Detection of necrotic malignant tissue and associated therapy

Vasopermeability enhancing immunoconjugates

Vasopermeability enhancing peptide of human interleukin-2 and immun...

Antibodies with reduced net positive charge

Detection of necrotic malignant tissue and associated therapy

Modified antibodies

Patents Applicationslast 30 patents

CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS

CpG IMMUNOCONJUGATES FOR CANCER THERAPY

HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER...

LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS

CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

HUMANIZED ANTI-NUCLEAR ANTIBODIES FOR TARGETING NECROSIS IN CANCER...

TUMOR NECROSIS TARGETING COMPOSITIONS AND METHODS

CD20 scFv-ELPs METHODS AND THERAPEUTICS

CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USE THEREOF

GITR AGONISTS, AND METHODS OF USE THEREOF

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

SECRETORY TNT CAR CELL IMMUNOTHERAPY

CAR T-CELLS FOR THE TREATMENT OF B7-H4 EXPRESSING SOLID TUMORS

CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS

LYM-1 AND LYM-2 TARGETED CAR CELL IMMUNOTHERAPY

CD20 scFv-ELPs METHODS AND THERAPEUTICS

HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS

OX40L FUSION PROTEIN FOR THE IMMUNOTHERAPY OF TUMORS OF VETERINARY...

COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY

HUMAN MYELOID DERIVED SUPPRESSOR CELL CANCER MARKERS

CANCER TARGETED INNATE IMMUNITY

THERAPEUTIC USE OF INTERLEUKIN-2 MUTANTS

COMBINATION CANCER IMMUNOTHERAPY WITH CO-STIMULATORY MOLECULES

COMBINATION CANCER IMMUNOTHERAPY WITH CO-STIMULATORY MOLECULES

INTERLEUKIN-2 MUTANTS WITH REDUCED TOXICITY

COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY

Interleukin-2 mutants with reduced toxicity